TRVN

Trevena, Inc.
TRVN

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

TRVN was delisted on the 7th of October, 2024.

Back to rankings
 

About: Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.

Employees: 23

Healthcare Drug Manufacturers - General
Price charts implemented using Lightweight Charts™